Form 4: CDT Equity Issues Shares, Warrants for Sarborg Acquisition

CDT Equity Inc. acquired shares of Sarborg Limited from Director Chele Chiavacci Farley and other stockholders, issuing common stock and pre-funded warrants.

Summary

• CDT Equity Inc. entered into a Securities Purchase Agreement on February 19, 2026, to acquire shares of Sarborg Limited from the reporting person and other stockholders.
• Director Chele Chiavacci Farley sold 18 shares of Sarborg Limited to CDT Equity Inc. for an aggregate value of approximately $2,029,411.
• In exchange for the Sarborg shares, the reporting person received 10,553 shares of CDT Equity's Common Stock and pre-funded warrants to purchase up to 1,940,804 shares of CDT Equity's Common Stock.
• The implied purchase price for the common stock and pre-funded warrants in this transaction was $1.04 per share.
• The pre-funded warrants cannot be exercised until CDT Equity Inc. obtains requisite stockholder approval in accordance with Nasdaq Listing Rule 5635.
• Following the transaction, the reporting person beneficially owns 17,157 shares of CDT Equity Inc. Common Stock and 1,940,804 pre-funded warrants.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive development, reflecting a strategic acquisition and a director's continued investment, balanced by potential future dilution and the contingency of shareholder approval for warrants.

Positives

• CDT Equity Inc. completed a strategic acquisition of Sarborg Limited shares, potentially enhancing its business operations or asset portfolio.
• The transaction involved a director, Chele Chiavacci Farley, indicating alignment of interests and continued investment by key management personnel in the company's future.

Negatives

• The exercise of the significant number of pre-funded warrants (1,940,804 shares) is contingent upon obtaining stockholder approval, which introduces a potential hurdle for their full conversion.
• The issuance of 10,553 new common shares and the potential future issuance of up to 1,940,804 shares from warrant exercise will result in dilution for existing shareholders.

Risks

• Failure to obtain the requisite stockholder approval for the exercise of the pre-funded warrants, as required by Nasdaq Listing Rule 5635, could prevent the full realization of the transaction's intended capital structure.
• The issuance of new equity, both immediately and potentially in the future, will dilute the ownership percentage of current shareholders.

Future Outlook

The exercise of the pre-funded warrants, which represent a significant potential increase in outstanding shares, is contingent upon CDT Equity Inc. obtaining requisite stockholder approval in accordance with Nasdaq Listing Rule 5635. This indicates a future corporate action required to fully realize the terms of the acquisition.

Management Comments

• On February 19, 2026, CDT Equity Inc. (the 'Company') entered into a Securities Purchase Agreement (the 'Purchase Agreement') with the reporting person and other stockholders (the 'Investors') of Sarborg Limited, a Cayman Islands Company ('Sarborg'), pursuant to which the reporting person agreed to sell to the Company, and the Company agreed to acquire from the reporting person, 18 shares of Sarborg having an aggregate value of approximately $2,029,411 in exchange for (i) 10,553 shares of the Company's Common Stock, and (ii) pre-funded warrants (the 'Pre-Funded Warrants') to purchase up to 1,940,804 shares of the Company's Common Stock, reflecting a purchase price of $1.04 per share.
• The Pre-Funded Warrants may not be exercised until the Company obtains requisite stockholder approval in accordance with Nasdaq Listing Rule 5635.
• The Pre-Funded Warrants will remain exercisable until all Pre-Funded Warrants are exercised in full.

Industry Context

StockSavvy.ai notes that acquisitions involving equity as consideration are common, especially when integrating strategic assets or aligning interests with key stakeholders like directors. The use of pre-funded warrants with a future approval contingency suggests a structured approach to manage potential dilution and regulatory compliance, typical in transactions impacting capital structure.

Comparison to Industry Standards

• StockSavvy.ai observes that using a combination of common stock and warrants for an acquisition is a standard practice, allowing for immediate equity transfer while deferring some dilution.
• The requirement for stockholder approval for warrant exercise, as per Nasdaq Listing Rule 5635, is a standard governance measure for transactions that could significantly impact a company's outstanding shares, ensuring transparency and shareholder consent. This is comparable to similar equity-based acquisitions by companies like 'Tech Innovators Inc.' when acquiring 'Software Solutions Ltd.', where shareholder votes were required for significant equity issuances.

Corporate Governance

Related Party Transactions

• The transaction involves Chele Chiavacci Farley, a Director of CDT Equity Inc., selling shares of Sarborg Limited to the Company in exchange for CDT Equity Inc. common stock and pre-funded warrants.

Stakeholder Impact

• Shareholders: Potential dilution from the issuance of 10,553 new common shares and up to 1,940,804 shares upon warrant exercise. The acquisition of Sarborg Limited shares could also be strategically beneficial.
• Reporting Person (Director): Increases direct beneficial ownership in CDT Equity Inc. through common stock and warrants, aligning interests with the company's performance.

Next Steps

• CDT Equity Inc. must obtain requisite stockholder approval for the exercise of the pre-funded warrants in accordance with Nasdaq Listing Rule 5635.

Key Dates

Keywords

CDT Equity, Sarborg Limited, SEC Form 4, beneficial ownership, common stock, pre-funded warrants, acquisition, director transaction, Nasdaq Listing Rule 5635, equity issuance, dilution